Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Antigen, T-Cell | 50 | 2023 | 2568 | 4.720 |
Why?
|
Histocompatibility Antigens Class II | 25 | 2025 | 1442 | 3.050 |
Why?
|
HLA-D Antigens | 11 | 2013 | 130 | 2.330 |
Why?
|
Antigen Presentation | 20 | 2025 | 1250 | 2.310 |
Why?
|
Killer Cells, Natural | 15 | 2024 | 2209 | 2.220 |
Why?
|
T-Lymphocytes | 59 | 2024 | 10254 | 2.180 |
Why?
|
Histocompatibility Antigens Class I | 17 | 2024 | 1362 | 2.080 |
Why?
|
Peptides | 31 | 2025 | 4348 | 1.930 |
Why?
|
HLA-DR2 Antigen | 17 | 2011 | 44 | 1.820 |
Why?
|
CD8-Positive T-Lymphocytes | 24 | 2024 | 4648 | 1.780 |
Why?
|
T-Lymphocytes, Cytotoxic | 11 | 2020 | 1801 | 1.710 |
Why?
|
CD4-Positive T-Lymphocytes | 23 | 2025 | 4405 | 1.660 |
Why?
|
Autoantigens | 17 | 2013 | 890 | 1.600 |
Why?
|
Immunotherapy | 26 | 2024 | 4745 | 1.510 |
Why?
|
Autoimmunity | 16 | 2018 | 1361 | 1.420 |
Why?
|
Antigens, Neoplasm | 13 | 2025 | 1997 | 1.360 |
Why?
|
Neoplasms | 22 | 2024 | 22350 | 1.210 |
Why?
|
Histocompatibility Antigens | 5 | 2014 | 479 | 1.190 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 4 | 2025 | 318 | 1.180 |
Why?
|
Immunological Synapses | 4 | 2017 | 58 | 1.140 |
Why?
|
Lymphocyte Activation | 31 | 2023 | 5499 | 1.140 |
Why?
|
Multiple Sclerosis | 28 | 2018 | 3229 | 1.010 |
Why?
|
Tumor Escape | 4 | 2021 | 371 | 1.000 |
Why?
|
Autoimmune Diseases | 16 | 2014 | 2255 | 0.990 |
Why?
|
Cell Membrane | 9 | 2016 | 3642 | 0.980 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 2 | 2024 | 85 | 0.950 |
Why?
|
HLA-DR Antigens | 12 | 2009 | 609 | 0.940 |
Why?
|
Amino Acid Sequence | 57 | 2018 | 13411 | 0.920 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 9 | 2022 | 1105 | 0.900 |
Why?
|
B-Lymphocytes | 16 | 2020 | 4787 | 0.870 |
Why?
|
Melanoma | 10 | 2023 | 5702 | 0.870 |
Why?
|
Immunity, Cellular | 4 | 2024 | 1560 | 0.860 |
Why?
|
Receptor-CD3 Complex, Antigen, T-Cell | 5 | 2010 | 67 | 0.860 |
Why?
|
Cytokines | 14 | 2023 | 7446 | 0.860 |
Why?
|
Myelin-Associated Glycoprotein | 3 | 2009 | 110 | 0.850 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily K | 8 | 2024 | 94 | 0.830 |
Why?
|
Major Histocompatibility Complex | 4 | 2014 | 879 | 0.820 |
Why?
|
Melanoma, Experimental | 5 | 2018 | 557 | 0.820 |
Why?
|
Molecular Sequence Data | 56 | 2013 | 17608 | 0.790 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 14 | 2010 | 812 | 0.790 |
Why?
|
Receptors, Immunologic | 8 | 2010 | 1418 | 0.790 |
Why?
|
Peptide Fragments | 29 | 2012 | 5141 | 0.790 |
Why?
|
Skin Diseases, Genetic | 1 | 2022 | 49 | 0.760 |
Why?
|
Animals | 120 | 2025 | 168965 | 0.760 |
Why?
|
Antigens | 5 | 2020 | 1442 | 0.740 |
Why?
|
Tumor Microenvironment | 14 | 2024 | 3944 | 0.740 |
Why?
|
Glioblastoma | 9 | 2025 | 3461 | 0.730 |
Why?
|
SOXC Transcription Factors | 1 | 2020 | 41 | 0.730 |
Why?
|
Models, Molecular | 22 | 2018 | 5388 | 0.720 |
Why?
|
Epitopes, T-Lymphocyte | 9 | 2019 | 827 | 0.710 |
Why?
|
Autoantibodies | 10 | 2015 | 2114 | 0.700 |
Why?
|
Protein-Arginine N-Methyltransferases | 1 | 2021 | 129 | 0.690 |
Why?
|
Mice | 87 | 2025 | 81912 | 0.690 |
Why?
|
Fluorescence Resonance Energy Transfer | 4 | 2017 | 415 | 0.680 |
Why?
|
Signal Transduction | 22 | 2023 | 23621 | 0.680 |
Why?
|
Encephalomyelitis, Acute Disseminated | 3 | 2015 | 68 | 0.660 |
Why?
|
Databases, Protein | 1 | 2021 | 390 | 0.650 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2021 | 513 | 0.650 |
Why?
|
Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 2 | 2016 | 93 | 0.640 |
Why?
|
Immunologic Memory | 8 | 2024 | 1377 | 0.630 |
Why?
|
Diabetes Mellitus, Type 1 | 14 | 2017 | 3449 | 0.630 |
Why?
|
HLA-DQ Antigens | 7 | 2011 | 190 | 0.610 |
Why?
|
Antibodies, Monoclonal | 10 | 2024 | 9245 | 0.590 |
Why?
|
Glioma | 3 | 2022 | 3502 | 0.580 |
Why?
|
Antibodies, Blocking | 1 | 2018 | 250 | 0.570 |
Why?
|
Cytotoxicity, Immunologic | 5 | 2024 | 1352 | 0.570 |
Why?
|
Myeloid Cells | 2 | 2020 | 837 | 0.570 |
Why?
|
Arenaviridae Infections | 1 | 2017 | 53 | 0.560 |
Why?
|
Receptors, Chemokine | 1 | 2020 | 652 | 0.560 |
Why?
|
Integrins | 2 | 2020 | 840 | 0.550 |
Why?
|
Cell Line, Tumor | 26 | 2025 | 17097 | 0.550 |
Why?
|
Myelin Proteins | 4 | 2009 | 212 | 0.540 |
Why?
|
HLA-A Antigens | 4 | 2013 | 223 | 0.540 |
Why?
|
Histone Deacetylases | 2 | 2021 | 712 | 0.540 |
Why?
|
T-Lymphocytes, Regulatory | 9 | 2020 | 3114 | 0.510 |
Why?
|
Humans | 188 | 2025 | 767040 | 0.500 |
Why?
|
Mice, Inbred NOD | 14 | 2020 | 1837 | 0.470 |
Why?
|
Immunodominant Epitopes | 10 | 2007 | 244 | 0.470 |
Why?
|
Neoplasm Metastasis | 3 | 2019 | 4892 | 0.460 |
Why?
|
Protein Binding | 22 | 2018 | 9327 | 0.440 |
Why?
|
Mice, Inbred C57BL | 24 | 2025 | 22361 | 0.440 |
Why?
|
HLA-DR1 Antigen | 2 | 2012 | 11 | 0.440 |
Why?
|
Vaccines | 1 | 2022 | 842 | 0.430 |
Why?
|
Membrane Lipids | 2 | 2012 | 241 | 0.430 |
Why?
|
Chromosomal Proteins, Non-Histone | 2 | 2020 | 724 | 0.430 |
Why?
|
Dimerization | 10 | 2010 | 882 | 0.430 |
Why?
|
Cyclin-Dependent Kinase 4 | 4 | 2021 | 562 | 0.430 |
Why?
|
Gene Expression Regulation, Neoplastic | 9 | 2023 | 8628 | 0.420 |
Why?
|
Cyclin-Dependent Kinase 6 | 3 | 2021 | 352 | 0.410 |
Why?
|
Nitric Oxide | 2 | 2021 | 2140 | 0.410 |
Why?
|
Epitope Mapping | 2 | 2013 | 301 | 0.410 |
Why?
|
Ligands | 9 | 2022 | 3273 | 0.410 |
Why?
|
T-Lymphocyte Subsets | 8 | 2021 | 1814 | 0.400 |
Why?
|
Viral Proteins | 5 | 2013 | 1801 | 0.400 |
Why?
|
Single-Cell Analysis | 7 | 2021 | 2538 | 0.400 |
Why?
|
Hematologic Neoplasms | 1 | 2024 | 1907 | 0.390 |
Why?
|
Myelodysplastic Syndromes | 1 | 2022 | 1399 | 0.390 |
Why?
|
Protein Phosphatase 2 | 1 | 2014 | 231 | 0.390 |
Why?
|
Genes, MHC Class II | 4 | 2004 | 433 | 0.380 |
Why?
|
Colitis | 1 | 2020 | 1238 | 0.380 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 2 | 2010 | 354 | 0.380 |
Why?
|
Jurkat Cells | 4 | 2017 | 740 | 0.380 |
Why?
|
Protein Structure, Tertiary | 11 | 2018 | 3760 | 0.370 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 10 | 2018 | 820 | 0.370 |
Why?
|
Immunomodulation | 3 | 2020 | 548 | 0.370 |
Why?
|
Genes, MHC Class I | 2 | 2023 | 236 | 0.360 |
Why?
|
Epitopes | 11 | 2021 | 2526 | 0.360 |
Why?
|
Cross Reactions | 10 | 2018 | 828 | 0.350 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2021 | 2952 | 0.350 |
Why?
|
Lung Neoplasms | 4 | 2024 | 13491 | 0.340 |
Why?
|
Molecular Mimicry | 4 | 2001 | 212 | 0.340 |
Why?
|
Dendritic Cells | 6 | 2025 | 2745 | 0.330 |
Why?
|
Head and Neck Neoplasms | 1 | 2024 | 2930 | 0.330 |
Why?
|
Drug Resistance, Neoplasm | 6 | 2021 | 5332 | 0.320 |
Why?
|
Membrane Proteins | 9 | 2018 | 7868 | 0.310 |
Why?
|
Crystallography, X-Ray | 8 | 2013 | 1947 | 0.310 |
Why?
|
Mutant Proteins | 1 | 2010 | 487 | 0.310 |
Why?
|
Neuromyelitis Optica | 2 | 2015 | 266 | 0.310 |
Why?
|
Protein Conformation | 9 | 2012 | 3948 | 0.300 |
Why?
|
Viral Matrix Proteins | 2 | 2020 | 193 | 0.300 |
Why?
|
Inflammation | 5 | 2021 | 10869 | 0.300 |
Why?
|
Sequence Alignment | 8 | 2018 | 2176 | 0.290 |
Why?
|
Lymphocytic choriomeningitis virus | 2 | 2020 | 176 | 0.290 |
Why?
|
Superantigens | 4 | 2007 | 124 | 0.290 |
Why?
|
RNA Interference | 1 | 2016 | 2829 | 0.290 |
Why?
|
HLA-B27 Antigen | 2 | 2004 | 66 | 0.280 |
Why?
|
Clone Cells | 15 | 2020 | 1669 | 0.280 |
Why?
|
Molecular Targeted Therapy | 2 | 2021 | 2824 | 0.280 |
Why?
|
Mice, Transgenic | 21 | 2021 | 9551 | 0.280 |
Why?
|
Thymus Gland | 5 | 2011 | 1264 | 0.270 |
Why?
|
Sequence Analysis, RNA | 5 | 2021 | 2040 | 0.270 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3828 | 0.270 |
Why?
|
Herpesvirus 4, Human | 5 | 2020 | 1079 | 0.270 |
Why?
|
HLA Antigens | 4 | 2019 | 1334 | 0.270 |
Why?
|
Cancer Vaccines | 5 | 2021 | 1041 | 0.260 |
Why?
|
Human T-lymphotropic virus 1 | 4 | 2007 | 143 | 0.260 |
Why?
|
Tetracycline | 1 | 2006 | 216 | 0.260 |
Why?
|
Immunotherapy, Adoptive | 5 | 2023 | 1502 | 0.260 |
Why?
|
Structure-Activity Relationship | 6 | 2010 | 3052 | 0.260 |
Why?
|
Immune Tolerance | 5 | 2017 | 2322 | 0.250 |
Why?
|
Binding Sites | 11 | 2013 | 6014 | 0.250 |
Why?
|
Chemokines | 2 | 2020 | 963 | 0.250 |
Why?
|
Bacterial Proteins | 4 | 2018 | 3834 | 0.250 |
Why?
|
Models, Immunological | 4 | 2007 | 516 | 0.250 |
Why?
|
Cell Separation | 1 | 2011 | 1717 | 0.250 |
Why?
|
MicroRNAs | 3 | 2017 | 3792 | 0.250 |
Why?
|
Viremia | 2 | 2005 | 726 | 0.250 |
Why?
|
Flow Cytometry | 11 | 2020 | 5891 | 0.240 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 5389 | 0.240 |
Why?
|
Receptors, Fc | 2 | 2023 | 537 | 0.240 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2020 | 3608 | 0.240 |
Why?
|
Mice, Knockout | 11 | 2020 | 14476 | 0.240 |
Why?
|
Central Nervous System | 4 | 2011 | 1345 | 0.240 |
Why?
|
Base Sequence | 17 | 2020 | 12414 | 0.240 |
Why?
|
Lectins, C-Type | 3 | 2021 | 591 | 0.230 |
Why?
|
Skin Neoplasms | 3 | 2019 | 5859 | 0.230 |
Why?
|
Macromolecular Substances | 8 | 2004 | 1430 | 0.230 |
Why?
|
Immunocompetence | 2 | 2018 | 138 | 0.230 |
Why?
|
Tyrosine | 1 | 2008 | 1425 | 0.230 |
Why?
|
Endoplasmic Reticulum | 3 | 2005 | 1132 | 0.220 |
Why?
|
Azepines | 3 | 2020 | 329 | 0.220 |
Why?
|
Neoplasms, Experimental | 2 | 2019 | 1228 | 0.220 |
Why?
|
Immunoassay | 1 | 2007 | 744 | 0.210 |
Why?
|
Gene Products, tax | 2 | 2001 | 51 | 0.210 |
Why?
|
Neoadjuvant Therapy | 3 | 2024 | 2902 | 0.210 |
Why?
|
Receptors, Natural Killer Cell | 4 | 2007 | 56 | 0.210 |
Why?
|
Protein Interaction Domains and Motifs | 3 | 2018 | 447 | 0.210 |
Why?
|
Phosphorylation | 6 | 2023 | 8310 | 0.200 |
Why?
|
Interferon-gamma | 6 | 2022 | 3154 | 0.200 |
Why?
|
Complementarity Determining Regions | 4 | 2019 | 154 | 0.200 |
Why?
|
Antigen-Presenting Cells | 8 | 2014 | 960 | 0.200 |
Why?
|
Sequence Homology, Amino Acid | 5 | 2018 | 2745 | 0.200 |
Why?
|
Cell Proliferation | 9 | 2020 | 10455 | 0.190 |
Why?
|
Immunoblotting | 2 | 2017 | 1647 | 0.190 |
Why?
|
Antigens, Viral | 5 | 2018 | 994 | 0.190 |
Why?
|
Transcription Factors | 4 | 2023 | 12158 | 0.180 |
Why?
|
alpha-Mannosidase | 1 | 2020 | 19 | 0.180 |
Why?
|
Glutarates | 1 | 2022 | 242 | 0.180 |
Why?
|
HLA-A2 Antigen | 3 | 2003 | 207 | 0.180 |
Why?
|
T-Cell Antigen Receptor Specificity | 3 | 2018 | 89 | 0.180 |
Why?
|
Protein Structure, Secondary | 3 | 2013 | 1211 | 0.180 |
Why?
|
Microscopy, Fluorescence | 4 | 2019 | 2628 | 0.180 |
Why?
|
Clonal Anergy | 1 | 2001 | 169 | 0.180 |
Why?
|
Hepacivirus | 2 | 2008 | 1342 | 0.180 |
Why?
|
Periodicals as Topic | 1 | 2011 | 1465 | 0.180 |
Why?
|
Core Binding Factor Alpha 3 Subunit | 1 | 2020 | 58 | 0.170 |
Why?
|
Intercellular Adhesion Molecule-1 | 3 | 2014 | 1132 | 0.170 |
Why?
|
Chaperonin 60 | 1 | 2000 | 97 | 0.170 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2021 | 200 | 0.170 |
Why?
|
Primary Myelofibrosis | 1 | 2022 | 208 | 0.170 |
Why?
|
Chemokines, C | 1 | 2019 | 10 | 0.170 |
Why?
|
Amino Acid Motifs | 3 | 2008 | 928 | 0.170 |
Why?
|
Brain Neoplasms | 5 | 2025 | 9108 | 0.170 |
Why?
|
Central Nervous System Diseases | 2 | 1998 | 518 | 0.170 |
Why?
|
Phenylenediamines | 1 | 2020 | 89 | 0.170 |
Why?
|
Cells, Cultured | 12 | 2021 | 18989 | 0.170 |
Why?
|
Immunoglobulin A | 2 | 2019 | 992 | 0.170 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2023 | 546 | 0.170 |
Why?
|
Cross-Priming | 1 | 2019 | 75 | 0.170 |
Why?
|
Glutamate Decarboxylase | 1 | 2000 | 239 | 0.160 |
Why?
|
Oncolytic Viruses | 1 | 2023 | 344 | 0.160 |
Why?
|
Sarcoma, Synovial | 1 | 2021 | 156 | 0.160 |
Why?
|
Phagocytes | 1 | 2021 | 292 | 0.160 |
Why?
|
Protein Precursors | 1 | 2003 | 1134 | 0.160 |
Why?
|
Receptors, CXCR3 | 1 | 2020 | 240 | 0.160 |
Why?
|
Static Electricity | 2 | 2012 | 258 | 0.160 |
Why?
|
Cell Dedifferentiation | 1 | 2020 | 125 | 0.160 |
Why?
|
Solubility | 6 | 2002 | 1078 | 0.160 |
Why?
|
Cricetulus | 2 | 2011 | 810 | 0.160 |
Why?
|
Neoplasm Transplantation | 2 | 2020 | 2012 | 0.160 |
Why?
|
Histone Code | 1 | 2020 | 160 | 0.160 |
Why?
|
Gene Rearrangement, T-Lymphocyte | 2 | 1995 | 111 | 0.160 |
Why?
|
Lipid Bilayers | 2 | 2012 | 377 | 0.150 |
Why?
|
Hemorrhagic Fever, American | 1 | 2018 | 12 | 0.150 |
Why?
|
Junin virus | 1 | 2018 | 13 | 0.150 |
Why?
|
Gelatinases | 1 | 2018 | 93 | 0.150 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2021 | 777 | 0.150 |
Why?
|
Antigens, CD | 3 | 2018 | 4032 | 0.150 |
Why?
|
Acrylamides | 1 | 2020 | 261 | 0.150 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 2 | 2012 | 391 | 0.150 |
Why?
|
Arenaviruses, New World | 1 | 2018 | 34 | 0.150 |
Why?
|
CHO Cells | 2 | 2011 | 1376 | 0.150 |
Why?
|
Recombinant Proteins | 10 | 2011 | 6507 | 0.150 |
Why?
|
HMGB Proteins | 1 | 2018 | 45 | 0.150 |
Why?
|
Catalysis | 3 | 2010 | 766 | 0.150 |
Why?
|
Herpesvirus 1, Human | 1 | 2023 | 743 | 0.150 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2019 | 306 | 0.150 |
Why?
|
Oncolytic Virotherapy | 1 | 2023 | 520 | 0.150 |
Why?
|
Gene Expression Profiling | 4 | 2021 | 9532 | 0.140 |
Why?
|
Interleukin-2 | 7 | 2019 | 1894 | 0.140 |
Why?
|
HTLV-I Infections | 4 | 2002 | 104 | 0.140 |
Why?
|
Acetylation | 1 | 2020 | 1055 | 0.140 |
Why?
|
Cricetinae | 2 | 2011 | 2415 | 0.140 |
Why?
|
Ependymoma | 1 | 2020 | 328 | 0.140 |
Why?
|
Gene Expression Regulation | 6 | 2021 | 11923 | 0.140 |
Why?
|
Multigene Family | 1 | 2020 | 1081 | 0.140 |
Why?
|
Gene Knock-In Techniques | 1 | 2018 | 419 | 0.140 |
Why?
|
Models, Chemical | 2 | 2010 | 607 | 0.140 |
Why?
|
Interferon Type I | 2 | 2019 | 568 | 0.140 |
Why?
|
Lysine | 2 | 2020 | 998 | 0.140 |
Why?
|
Protein Kinase C-epsilon | 1 | 2016 | 43 | 0.140 |
Why?
|
Intestines | 3 | 2020 | 1905 | 0.140 |
Why?
|
Immunity, Innate | 3 | 2019 | 3076 | 0.130 |
Why?
|
Mice, Inbred BALB C | 11 | 2022 | 6226 | 0.130 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2018 | 446 | 0.130 |
Why?
|
Mice, SCID | 2 | 2020 | 2626 | 0.130 |
Why?
|
Cholangiocarcinoma | 1 | 2022 | 561 | 0.130 |
Why?
|
Bile Duct Neoplasms | 1 | 2022 | 614 | 0.130 |
Why?
|
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 2 | 1993 | 40 | 0.130 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2022 | 951 | 0.130 |
Why?
|
Antibodies, Viral | 2 | 2018 | 3212 | 0.130 |
Why?
|
Oncogenes | 2 | 2021 | 1232 | 0.130 |
Why?
|
Biomedical Research | 1 | 2011 | 3464 | 0.130 |
Why?
|
Lymph Nodes | 4 | 2025 | 3468 | 0.130 |
Why?
|
Myelin Proteolipid Protein | 3 | 2005 | 107 | 0.130 |
Why?
|
Receptors, Androgen | 1 | 2022 | 1089 | 0.130 |
Why?
|
Antigens, Bacterial | 2 | 1999 | 1148 | 0.130 |
Why?
|
Transforming Growth Factor beta | 2 | 2020 | 1995 | 0.120 |
Why?
|
Polyglycolic Acid | 1 | 2017 | 406 | 0.120 |
Why?
|
Immunity, Mucosal | 1 | 2019 | 499 | 0.120 |
Why?
|
Protein Engineering | 2 | 2011 | 554 | 0.120 |
Why?
|
Receptors, KIR | 2 | 2006 | 114 | 0.120 |
Why?
|
Apoptosis | 4 | 2022 | 9513 | 0.120 |
Why?
|
Immune Evasion | 1 | 2019 | 375 | 0.120 |
Why?
|
Mouth Neoplasms | 1 | 2020 | 597 | 0.120 |
Why?
|
Proteins | 2 | 2020 | 6001 | 0.120 |
Why?
|
Histones | 3 | 2020 | 2597 | 0.120 |
Why?
|
Tumor Cells, Cultured | 3 | 2020 | 6106 | 0.120 |
Why?
|
Protein Kinase Inhibitors | 3 | 2021 | 5693 | 0.120 |
Why?
|
NFATC Transcription Factors | 1 | 2017 | 393 | 0.120 |
Why?
|
Endonucleases | 1 | 2018 | 371 | 0.120 |
Why?
|
Receptors, IgG | 1 | 2018 | 563 | 0.120 |
Why?
|
HEK293 Cells | 4 | 2020 | 4280 | 0.120 |
Why?
|
Pemphigus | 1 | 1995 | 107 | 0.120 |
Why?
|
HLA-DR4 Antigen | 2 | 2012 | 22 | 0.120 |
Why?
|
Viral Envelope Proteins | 1 | 2018 | 640 | 0.120 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2017 | 857 | 0.120 |
Why?
|
Oligodendroglia | 1 | 2018 | 539 | 0.110 |
Why?
|
Intestinal Mucosa | 3 | 2020 | 3043 | 0.110 |
Why?
|
Gene Knockdown Techniques | 2 | 2019 | 1604 | 0.110 |
Why?
|
Cell Movement | 4 | 2014 | 5203 | 0.110 |
Why?
|
Disease Models, Animal | 7 | 2021 | 18330 | 0.110 |
Why?
|
Oligopeptides | 1 | 1999 | 1195 | 0.110 |
Why?
|
Female | 42 | 2025 | 396660 | 0.110 |
Why?
|
Kinetics | 4 | 2019 | 6287 | 0.110 |
Why?
|
Gene Silencing | 1 | 2020 | 1505 | 0.110 |
Why?
|
Gene Rearrangement, delta-Chain T-Cell Antigen Receptor | 1 | 1993 | 15 | 0.110 |
Why?
|
Binding Sites, Antibody | 3 | 2018 | 340 | 0.110 |
Why?
|
Serine Endopeptidases | 1 | 2018 | 1027 | 0.110 |
Why?
|
Secretory Vesicles | 1 | 2014 | 127 | 0.110 |
Why?
|
Models, Biological | 6 | 2020 | 9464 | 0.100 |
Why?
|
HIV-1 | 2 | 2012 | 6951 | 0.100 |
Why?
|
Optic Neuritis | 1 | 2015 | 173 | 0.100 |
Why?
|
Stromal Cells | 1 | 2018 | 1335 | 0.100 |
Why?
|
B-Lymphocyte Subsets | 1 | 2014 | 240 | 0.100 |
Why?
|
Demyelinating Diseases | 3 | 2015 | 354 | 0.100 |
Why?
|
Stem Cells | 3 | 2020 | 3535 | 0.100 |
Why?
|
DNA Replication | 1 | 2020 | 1426 | 0.100 |
Why?
|
DNA Primers | 5 | 2011 | 2827 | 0.100 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2021 | 1608 | 0.100 |
Why?
|
Eukaryotic Initiation Factors | 1 | 2012 | 83 | 0.100 |
Why?
|
Carboxypeptidases | 1 | 2012 | 121 | 0.100 |
Why?
|
Surface Plasmon Resonance | 2 | 2010 | 268 | 0.100 |
Why?
|
Microscopy, Confocal | 3 | 2014 | 1969 | 0.100 |
Why?
|
Paraparesis, Tropical Spastic | 2 | 2007 | 32 | 0.100 |
Why?
|
Coculture Techniques | 3 | 2021 | 1337 | 0.100 |
Why?
|
Diabetes Mellitus, Experimental | 2 | 2017 | 1121 | 0.100 |
Why?
|
Mitosporic Fungi | 1 | 1991 | 17 | 0.100 |
Why?
|
Pleural Neoplasms | 1 | 2016 | 584 | 0.100 |
Why?
|
Central Nervous System Neoplasms | 1 | 2020 | 928 | 0.100 |
Why?
|
Leucine Zippers | 3 | 2011 | 116 | 0.100 |
Why?
|
Hepatitis C | 3 | 2008 | 1594 | 0.100 |
Why?
|
Lactic Acid | 1 | 2017 | 1139 | 0.090 |
Why?
|
Promoter Regions, Genetic | 2 | 2020 | 5796 | 0.090 |
Why?
|
Indoles | 1 | 2019 | 1836 | 0.090 |
Why?
|
Receptors, Cell Surface | 1 | 2021 | 2815 | 0.090 |
Why?
|
Phosphatidylserines | 1 | 2012 | 186 | 0.090 |
Why?
|
Nervous System Diseases | 1 | 2002 | 1660 | 0.090 |
Why?
|
Oxygen | 1 | 2023 | 4252 | 0.090 |
Why?
|
Membrane Glycoproteins | 4 | 2018 | 3702 | 0.090 |
Why?
|
Immunosuppressive Agents | 2 | 2022 | 4210 | 0.090 |
Why?
|
Food Microbiology | 1 | 1991 | 73 | 0.090 |
Why?
|
Polymorphism, Genetic | 5 | 2018 | 4247 | 0.090 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2017 | 3804 | 0.090 |
Why?
|
Hydrogels | 1 | 2017 | 729 | 0.090 |
Why?
|
Demyelinating Autoimmune Diseases, CNS | 2 | 2015 | 40 | 0.090 |
Why?
|
Ventricular Myosins | 1 | 2011 | 65 | 0.090 |
Why?
|
RNA, Double-Stranded | 1 | 2012 | 292 | 0.090 |
Why?
|
Structural Homology, Protein | 1 | 2011 | 86 | 0.090 |
Why?
|
Cadherins | 1 | 1995 | 903 | 0.090 |
Why?
|
Vaccination | 3 | 2023 | 3434 | 0.090 |
Why?
|
Cell Line | 11 | 2011 | 15567 | 0.090 |
Why?
|
DNA Damage | 1 | 2021 | 2469 | 0.090 |
Why?
|
Tissue Array Analysis | 1 | 2012 | 545 | 0.090 |
Why?
|
Tetanus Toxoid | 1 | 2011 | 188 | 0.090 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 3 | 2008 | 897 | 0.090 |
Why?
|
Antibody Specificity | 2 | 2011 | 1062 | 0.090 |
Why?
|
Antibodies, Neutralizing | 2 | 2018 | 2011 | 0.090 |
Why?
|
Cell Polarity | 1 | 2014 | 637 | 0.090 |
Why?
|
Mesothelioma | 1 | 2016 | 774 | 0.090 |
Why?
|
Multiprotein Complexes | 3 | 2007 | 1110 | 0.090 |
Why?
|
Neoplasm Proteins | 2 | 2019 | 3599 | 0.090 |
Why?
|
Myocarditis | 2 | 2011 | 802 | 0.090 |
Why?
|
Directed Molecular Evolution | 1 | 2011 | 167 | 0.090 |
Why?
|
Polysaccharides | 2 | 2020 | 1020 | 0.090 |
Why?
|
Macrophages | 2 | 2022 | 5785 | 0.080 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2019 | 2887 | 0.080 |
Why?
|
OX40 Ligand | 2 | 2020 | 57 | 0.080 |
Why?
|
Transduction, Genetic | 2 | 2019 | 899 | 0.080 |
Why?
|
Insulin | 2 | 2001 | 6602 | 0.080 |
Why?
|
Simplexvirus | 1 | 2013 | 805 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2025 | 9410 | 0.080 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily C | 2 | 2007 | 38 | 0.080 |
Why?
|
Neutrophils | 2 | 2019 | 3779 | 0.080 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 11872 | 0.080 |
Why?
|
Lymphoma | 1 | 2018 | 1896 | 0.080 |
Why?
|
Phenotype | 6 | 2020 | 16718 | 0.080 |
Why?
|
Baculoviridae | 3 | 2011 | 115 | 0.070 |
Why?
|
Spinal Cord | 2 | 2015 | 1811 | 0.070 |
Why?
|
Galectin 1 | 1 | 2009 | 128 | 0.070 |
Why?
|
Breast Neoplasms | 3 | 2021 | 21178 | 0.070 |
Why?
|
Transfection | 5 | 2019 | 5753 | 0.070 |
Why?
|
Crystallization | 2 | 1999 | 518 | 0.070 |
Why?
|
Amino Acid Substitution | 5 | 2007 | 1743 | 0.070 |
Why?
|
Receptors, Interleukin-2 | 3 | 2005 | 564 | 0.070 |
Why?
|
Radioimmunoassay | 2 | 2005 | 861 | 0.070 |
Why?
|
Hybridomas | 3 | 2011 | 442 | 0.070 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2011 | 658 | 0.070 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2010 | 1677 | 0.070 |
Why?
|
Photolysis | 1 | 2007 | 94 | 0.070 |
Why?
|
Neovascularization, Pathologic | 1 | 2017 | 2627 | 0.070 |
Why?
|
Transgenes | 1 | 2010 | 1014 | 0.070 |
Why?
|
Gene Knockout Techniques | 2 | 2021 | 804 | 0.070 |
Why?
|
Transmembrane Activator and CAML Interactor Protein | 1 | 2007 | 55 | 0.070 |
Why?
|
Nanotechnology | 1 | 2012 | 702 | 0.070 |
Why?
|
Photochemistry | 1 | 2007 | 239 | 0.070 |
Why?
|
DNA-Binding Proteins | 6 | 2018 | 9612 | 0.070 |
Why?
|
Epithelial Cells | 1 | 2019 | 3698 | 0.070 |
Why?
|
Ovarian Neoplasms | 1 | 2023 | 4903 | 0.070 |
Why?
|
Multiple Myeloma | 1 | 2024 | 5186 | 0.070 |
Why?
|
RNA, Messenger | 6 | 2012 | 12793 | 0.070 |
Why?
|
Transcription, Genetic | 1 | 2020 | 7611 | 0.070 |
Why?
|
Hydrogen Bonding | 1 | 2006 | 290 | 0.070 |
Why?
|
Common Variable Immunodeficiency | 1 | 2007 | 99 | 0.070 |
Why?
|
Male | 28 | 2025 | 364203 | 0.060 |
Why?
|
Protein Multimerization | 1 | 2011 | 961 | 0.060 |
Why?
|
src-Family Kinases | 1 | 2008 | 539 | 0.060 |
Why?
|
Blood Cells | 2 | 2005 | 309 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2022 | 3626 | 0.060 |
Why?
|
Fluoroimmunoassay | 1 | 2005 | 30 | 0.060 |
Why?
|
Beverages | 1 | 1991 | 819 | 0.060 |
Why?
|
Fruit | 1 | 1991 | 1165 | 0.060 |
Why?
|
Protein Folding | 2 | 2007 | 869 | 0.060 |
Why?
|
Receptors, Collagen | 1 | 2005 | 25 | 0.060 |
Why?
|
HIV Core Protein p24 | 1 | 2005 | 245 | 0.060 |
Why?
|
Spodoptera | 2 | 2011 | 140 | 0.060 |
Why?
|
Myelin Sheath | 1 | 2009 | 649 | 0.060 |
Why?
|
HIV Infections | 3 | 2014 | 17542 | 0.060 |
Why?
|
Enterotoxins | 1 | 2007 | 366 | 0.060 |
Why?
|
Calcium | 2 | 2017 | 5792 | 0.060 |
Why?
|
Th17 Cells | 1 | 2011 | 790 | 0.060 |
Why?
|
Microsomes | 1 | 2005 | 252 | 0.060 |
Why?
|
Cell Survival | 4 | 2017 | 5750 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2006 | 2902 | 0.060 |
Why?
|
Pancreatic Neoplasms | 1 | 2023 | 5446 | 0.060 |
Why?
|
Tissue Culture Techniques | 2 | 2019 | 287 | 0.060 |
Why?
|
Pseudomonas aeruginosa | 1 | 2013 | 1277 | 0.060 |
Why?
|
Up-Regulation | 3 | 2020 | 4143 | 0.060 |
Why?
|
Genetic Linkage | 2 | 2003 | 2342 | 0.060 |
Why?
|
Solutions | 1 | 2005 | 405 | 0.060 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2008 | 696 | 0.060 |
Why?
|
RNA, Small Interfering | 1 | 2014 | 3427 | 0.060 |
Why?
|
Triazoles | 2 | 2020 | 903 | 0.060 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2014 | 3667 | 0.060 |
Why?
|
Protein Structure, Quaternary | 1 | 2005 | 424 | 0.060 |
Why?
|
Genetic Testing | 1 | 2018 | 3591 | 0.060 |
Why?
|
HLA-DP Antigens | 1 | 2003 | 25 | 0.060 |
Why?
|
Aspartic Acid | 1 | 2006 | 575 | 0.060 |
Why?
|
Graft vs Host Disease | 1 | 2017 | 3049 | 0.060 |
Why?
|
Cytoplasm | 1 | 2008 | 1504 | 0.060 |
Why?
|
Polymerase Chain Reaction | 6 | 1992 | 6067 | 0.060 |
Why?
|
Fibroblasts | 1 | 2014 | 4167 | 0.060 |
Why?
|
Cathepsins | 1 | 2025 | 243 | 0.060 |
Why?
|
Peripheral Nervous System Diseases | 1 | 1990 | 716 | 0.060 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2006 | 502 | 0.060 |
Why?
|
Immunomagnetic Separation | 1 | 2003 | 78 | 0.050 |
Why?
|
Age Distribution | 1 | 2009 | 2870 | 0.050 |
Why?
|
Neuroglia | 1 | 2009 | 960 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 3 | 2004 | 3738 | 0.050 |
Why?
|
Precipitin Tests | 1 | 2004 | 816 | 0.050 |
Why?
|
Rats, Inbred ACI | 1 | 2022 | 34 | 0.050 |
Why?
|
Reproducibility of Results | 3 | 2023 | 20169 | 0.050 |
Why?
|
Homeostasis | 1 | 2014 | 3345 | 0.050 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2005 | 287 | 0.050 |
Why?
|
Transplantation Tolerance | 1 | 2008 | 639 | 0.050 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 1729 | 0.050 |
Why?
|
History, 20th Century | 1 | 2010 | 2765 | 0.050 |
Why?
|
Antigens, Protozoan | 2 | 2004 | 315 | 0.050 |
Why?
|
Mutagenesis | 1 | 2006 | 1227 | 0.050 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 2 | 2014 | 213 | 0.050 |
Why?
|
Spondylitis, Ankylosing | 1 | 2004 | 158 | 0.050 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2010 | 3684 | 0.050 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2003 | 246 | 0.050 |
Why?
|
Age of Onset | 1 | 2009 | 3344 | 0.050 |
Why?
|
Antibody Affinity | 1 | 2003 | 251 | 0.050 |
Why?
|
Ultraviolet Rays | 1 | 2007 | 1101 | 0.050 |
Why?
|
Haplotypes | 3 | 2001 | 2722 | 0.050 |
Why?
|
Gliadin | 1 | 2001 | 80 | 0.050 |
Why?
|
Oncostatin M Receptor beta Subunit | 1 | 2021 | 4 | 0.050 |
Why?
|
Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 2021 | 30 | 0.050 |
Why?
|
Cytokine Receptor gp130 | 1 | 2021 | 66 | 0.050 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2022 | 411 | 0.050 |
Why?
|
Oncostatin M | 1 | 2021 | 42 | 0.050 |
Why?
|
Bacterial Toxins | 1 | 2007 | 922 | 0.050 |
Why?
|
Disease Susceptibility | 3 | 2005 | 1791 | 0.050 |
Why?
|
Light | 1 | 2007 | 1358 | 0.050 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2006 | 976 | 0.050 |
Why?
|
Oligodeoxyribonucleotides | 2 | 1993 | 705 | 0.050 |
Why?
|
Influenza A virus | 1 | 2004 | 455 | 0.050 |
Why?
|
Genes, myc | 1 | 2022 | 391 | 0.050 |
Why?
|
Dexamethasone | 2 | 2018 | 1963 | 0.050 |
Why?
|
Leishmania major | 1 | 2000 | 60 | 0.040 |
Why?
|
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 2 | 1991 | 94 | 0.040 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2022 | 304 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2017 | 6550 | 0.040 |
Why?
|
Saccharomyces cerevisiae | 1 | 2011 | 2678 | 0.040 |
Why?
|
Alleles | 3 | 2007 | 6893 | 0.040 |
Why?
|
Immunoglobulin G | 3 | 2019 | 4560 | 0.040 |
Why?
|
Virus Replication | 2 | 2005 | 2457 | 0.040 |
Why?
|
Azides | 1 | 2020 | 120 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2025 | 8535 | 0.040 |
Why?
|
Interleukin-4 | 2 | 1995 | 1156 | 0.040 |
Why?
|
Piperazines | 2 | 2021 | 2548 | 0.040 |
Why?
|
Cysteine | 1 | 2004 | 896 | 0.040 |
Why?
|
Ploidies | 1 | 2020 | 287 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 7 | 2018 | 18063 | 0.040 |
Why?
|
Staining and Labeling | 2 | 2020 | 1076 | 0.040 |
Why?
|
Click Chemistry | 1 | 2020 | 100 | 0.040 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2011 | 1642 | 0.040 |
Why?
|
raf Kinases | 1 | 2019 | 117 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2022 | 11097 | 0.040 |
Why?
|
Breast Neoplasms, Male | 1 | 2021 | 213 | 0.040 |
Why?
|
Survival Analysis | 2 | 2023 | 10092 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2020 | 13650 | 0.040 |
Why?
|
Leishmaniasis, Cutaneous | 1 | 2000 | 137 | 0.040 |
Why?
|
Amino Acids | 2 | 2002 | 1712 | 0.040 |
Why?
|
Gene Expression | 3 | 1998 | 7587 | 0.040 |
Why?
|
Mutation | 5 | 2020 | 30211 | 0.040 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2004 | 551 | 0.040 |
Why?
|
Protozoan Proteins | 2 | 2004 | 843 | 0.040 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2003 | 2478 | 0.040 |
Why?
|
Pyridines | 2 | 2021 | 2890 | 0.040 |
Why?
|
Middle Aged | 12 | 2025 | 223233 | 0.040 |
Why?
|
Somatic Hypermutation, Immunoglobulin | 1 | 2019 | 103 | 0.040 |
Why?
|
Aged | 10 | 2025 | 171319 | 0.040 |
Why?
|
Neoplasm, Residual | 1 | 2023 | 1012 | 0.040 |
Why?
|
Antibody Formation | 1 | 2003 | 1392 | 0.040 |
Why?
|
Pentoxifylline | 1 | 1998 | 53 | 0.040 |
Why?
|
4-1BB Ligand | 1 | 2018 | 29 | 0.040 |
Why?
|
Adhesins, Bacterial | 1 | 1998 | 118 | 0.040 |
Why?
|
DNA Modification Methylases | 1 | 2018 | 207 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 1 | 2018 | 66 | 0.040 |
Why?
|
Myocardium | 1 | 2011 | 4765 | 0.040 |
Why?
|
Islets of Langerhans | 1 | 2004 | 1350 | 0.040 |
Why?
|
Bystander Effect | 1 | 2018 | 89 | 0.040 |
Why?
|
Encephalitis | 2 | 1999 | 441 | 0.040 |
Why?
|
Immune Sera | 1 | 2018 | 605 | 0.040 |
Why?
|
Herpes Simplex | 1 | 2001 | 470 | 0.040 |
Why?
|
Granzymes | 1 | 2019 | 277 | 0.040 |
Why?
|
Rats | 4 | 2022 | 23713 | 0.040 |
Why?
|
Immunoglobulin Variable Region | 1 | 2019 | 419 | 0.040 |
Why?
|
Lipids | 1 | 2008 | 3322 | 0.040 |
Why?
|
Blood Donors | 1 | 2019 | 343 | 0.040 |
Why?
|
Aminopyridines | 1 | 2021 | 578 | 0.030 |
Why?
|
Conserved Sequence | 1 | 2000 | 1160 | 0.030 |
Why?
|
Immunity | 1 | 2023 | 1002 | 0.030 |
Why?
|
Influenza Vaccines | 1 | 2004 | 780 | 0.030 |
Why?
|
Liver | 1 | 1993 | 7578 | 0.030 |
Why?
|
Toll-Like Receptor 8 | 1 | 2017 | 98 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2019 | 635 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2021 | 872 | 0.030 |
Why?
|
DNA Repair Enzymes | 1 | 2018 | 342 | 0.030 |
Why?
|
Drug Compounding | 1 | 2018 | 236 | 0.030 |
Why?
|
Serpins | 1 | 2018 | 246 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2022 | 998 | 0.030 |
Why?
|
Retinoblastoma Protein | 1 | 2020 | 670 | 0.030 |
Why?
|
Receptors, Transferrin | 1 | 2018 | 300 | 0.030 |
Why?
|
Telomerase | 1 | 2001 | 751 | 0.030 |
Why?
|
Metalloendopeptidases | 1 | 1998 | 386 | 0.030 |
Why?
|
Toll-Like Receptor 7 | 1 | 2017 | 169 | 0.030 |
Why?
|
Acute Disease | 3 | 2014 | 7236 | 0.030 |
Why?
|
Bone Marrow | 2 | 2022 | 2926 | 0.030 |
Why?
|
Endosomes | 1 | 1999 | 521 | 0.030 |
Why?
|
Desmoglein 3 | 1 | 1995 | 9 | 0.030 |
Why?
|
Forkhead Transcription Factors | 2 | 2018 | 1626 | 0.030 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2018 | 367 | 0.030 |
Why?
|
Hypoglycemic Agents | 1 | 2009 | 3108 | 0.030 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2019 | 647 | 0.030 |
Why?
|
Injections, Subcutaneous | 1 | 1997 | 685 | 0.030 |
Why?
|
Phagocytosis | 1 | 2022 | 1526 | 0.030 |
Why?
|
Drug Synergism | 1 | 2020 | 1759 | 0.030 |
Why?
|
Polymers | 2 | 2003 | 1624 | 0.030 |
Why?
|
Benzimidazoles | 1 | 2021 | 862 | 0.030 |
Why?
|
Cell Differentiation | 3 | 2022 | 11657 | 0.030 |
Why?
|
Pericytes | 1 | 2018 | 298 | 0.030 |
Why?
|
Blood-Brain Barrier | 1 | 2002 | 1029 | 0.030 |
Why?
|
Plasma Cells | 1 | 2019 | 599 | 0.030 |
Why?
|
Hydroxamic Acids | 1 | 1998 | 483 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 1997 | 1377 | 0.030 |
Why?
|
Transcriptional Activation | 2 | 2020 | 1751 | 0.030 |
Why?
|
Mice, Inbred DBA | 3 | 2001 | 624 | 0.030 |
Why?
|
T-Box Domain Proteins | 1 | 2018 | 471 | 0.030 |
Why?
|
Models, Theoretical | 1 | 2007 | 3561 | 0.030 |
Why?
|
Adult | 10 | 2025 | 223317 | 0.030 |
Why?
|
Brain | 3 | 2015 | 27163 | 0.030 |
Why?
|
Fibrosis | 1 | 2022 | 2078 | 0.030 |
Why?
|
Antigenic Variation | 1 | 1995 | 117 | 0.030 |
Why?
|
Endopeptidases | 1 | 2018 | 762 | 0.030 |
Why?
|
DNA, Neoplasm | 1 | 2020 | 1741 | 0.030 |
Why?
|
Protease Inhibitors | 1 | 1998 | 750 | 0.030 |
Why?
|
Protein Subunits | 1 | 2018 | 940 | 0.030 |
Why?
|
Receptors, Virus | 1 | 2018 | 652 | 0.030 |
Why?
|
Green Fluorescent Proteins | 2 | 2012 | 2063 | 0.030 |
Why?
|
Homeodomain Proteins | 1 | 2023 | 2429 | 0.030 |
Why?
|
B-Cell Activating Factor | 1 | 2014 | 116 | 0.030 |
Why?
|
Aquaporin 4 | 1 | 2015 | 161 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2025 | 65295 | 0.030 |
Why?
|
Antibodies | 2 | 2019 | 2419 | 0.030 |
Why?
|
Immunologic Surveillance | 1 | 1994 | 92 | 0.030 |
Why?
|
Virus Release | 1 | 2014 | 35 | 0.030 |
Why?
|
Prostate | 1 | 2022 | 1761 | 0.030 |
Why?
|
Fungal Proteins | 1 | 1998 | 901 | 0.030 |
Why?
|
Cell Line, Transformed | 1 | 1995 | 861 | 0.030 |
Why?
|
Celiac Disease | 1 | 2001 | 821 | 0.030 |
Why?
|
Cell Death | 1 | 2019 | 1677 | 0.030 |
Why?
|
Drosophila melanogaster | 2 | 2000 | 1722 | 0.030 |
Why?
|
pol Gene Products, Human Immunodeficiency Virus | 1 | 2012 | 41 | 0.030 |
Why?
|
Blotting, Southern | 2 | 1991 | 775 | 0.030 |
Why?
|
Safety | 1 | 1997 | 1157 | 0.030 |
Why?
|
Haptoglobins | 1 | 2014 | 165 | 0.030 |
Why?
|
Peptide Library | 1 | 2014 | 351 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2022 | 2883 | 0.030 |
Why?
|
Nylons | 1 | 2012 | 47 | 0.030 |
Why?
|
Viral Vaccines | 1 | 2018 | 596 | 0.030 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 2014 | 146 | 0.030 |
Why?
|
Monocytes | 1 | 2022 | 2598 | 0.030 |
Why?
|
Paclitaxel | 1 | 2020 | 1728 | 0.030 |
Why?
|
NF-kappa B | 1 | 2021 | 2493 | 0.030 |
Why?
|
Age Factors | 1 | 2009 | 18401 | 0.030 |
Why?
|
HTLV-I Antibodies | 1 | 1992 | 35 | 0.030 |
Why?
|
Endothelium, Lymphatic | 1 | 2012 | 63 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-vav | 1 | 2012 | 91 | 0.030 |
Why?
|
Genetic Engineering | 1 | 2018 | 935 | 0.030 |
Why?
|
Myosin Light Chains | 1 | 2012 | 121 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2022 | 2843 | 0.020 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2020 | 1244 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 1998 | 1612 | 0.020 |
Why?
|
Dimethylpolysiloxanes | 1 | 2012 | 142 | 0.020 |
Why?
|
Viral Load | 2 | 2014 | 3385 | 0.020 |
Why?
|
Immunohistochemistry | 4 | 2007 | 11063 | 0.020 |
Why?
|
Radiotherapy | 1 | 2018 | 1500 | 0.020 |
Why?
|
Galactans | 1 | 1991 | 31 | 0.020 |
Why?
|
Luminescent Proteins | 1 | 2014 | 839 | 0.020 |
Why?
|
Child | 4 | 2020 | 80771 | 0.020 |
Why?
|
Imidazoles | 1 | 2017 | 1169 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2022 | 8108 | 0.020 |
Why?
|
Chromatography, Gas | 1 | 1991 | 150 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 14672 | 0.020 |
Why?
|
Glucans | 1 | 1991 | 71 | 0.020 |
Why?
|
Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2012 | 163 | 0.020 |
Why?
|
Chromatography, Ion Exchange | 1 | 1991 | 292 | 0.020 |
Why?
|
Colloids | 1 | 1991 | 125 | 0.020 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2012 | 234 | 0.020 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2012 | 246 | 0.020 |
Why?
|
env Gene Products, Human Immunodeficiency Virus | 1 | 2014 | 381 | 0.020 |
Why?
|
Vesicular Transport Proteins | 1 | 2014 | 377 | 0.020 |
Why?
|
Carbohydrate Sequence | 1 | 1991 | 411 | 0.020 |
Why?
|
Autophagy | 1 | 2019 | 1347 | 0.020 |
Why?
|
Cardiac Myosins | 1 | 2011 | 128 | 0.020 |
Why?
|
Proviruses | 1 | 1992 | 319 | 0.020 |
Why?
|
Interleukin-10 | 1 | 1995 | 1182 | 0.020 |
Why?
|
Lymphoid Tissue | 1 | 2011 | 445 | 0.020 |
Why?
|
Adoptive Transfer | 2 | 2004 | 828 | 0.020 |
Why?
|
Immunity, Humoral | 1 | 2014 | 610 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2020 | 59548 | 0.020 |
Why?
|
HIV Envelope Protein gp120 | 1 | 2014 | 923 | 0.020 |
Why?
|
Child, Preschool | 3 | 2009 | 42606 | 0.020 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 1999 | 1836 | 0.020 |
Why?
|
Microglia | 2 | 1998 | 1370 | 0.020 |
Why?
|
Time Factors | 2 | 2011 | 40154 | 0.020 |
Why?
|
Myosin Heavy Chains | 1 | 2011 | 403 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2017 | 3611 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 1992 | 1697 | 0.020 |
Why?
|
Molecular Weight | 1 | 1991 | 2168 | 0.020 |
Why?
|
Platelet Activation | 1 | 2012 | 643 | 0.020 |
Why?
|
Computational Biology | 1 | 2021 | 3567 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2020 | 3440 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2018 | 2800 | 0.020 |
Why?
|
Nuclear Proteins | 2 | 2020 | 5794 | 0.020 |
Why?
|
Mesenchymal Stem Cells | 1 | 2019 | 1665 | 0.020 |
Why?
|
Injections, Intraperitoneal | 1 | 2009 | 411 | 0.020 |
Why?
|
Polyneuropathies | 1 | 1990 | 139 | 0.020 |
Why?
|
H-Y Antigen | 1 | 2008 | 42 | 0.020 |
Why?
|
HTLV-I Antigens | 1 | 2007 | 7 | 0.020 |
Why?
|
Genes, pX | 1 | 2007 | 7 | 0.020 |
Why?
|
Interleukin-1 | 1 | 1992 | 1252 | 0.020 |
Why?
|
Heat-Shock Proteins | 1 | 1992 | 792 | 0.020 |
Why?
|
Young Adult | 2 | 2018 | 59980 | 0.020 |
Why?
|
Chronic Disease | 2 | 2014 | 9362 | 0.020 |
Why?
|
Protein Transport | 1 | 2014 | 1944 | 0.020 |
Why?
|
Genome, Viral | 1 | 1992 | 673 | 0.020 |
Why?
|
Adolescent | 4 | 2015 | 89046 | 0.020 |
Why?
|
Chimerin Proteins | 1 | 2007 | 6 | 0.020 |
Why?
|
Receptors, CXCR4 | 1 | 2012 | 729 | 0.020 |
Why?
|
Pan troglodytes | 1 | 2008 | 224 | 0.020 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily D | 1 | 2007 | 30 | 0.020 |
Why?
|
Adaptive Immunity | 1 | 2012 | 733 | 0.020 |
Why?
|
Crystallography | 1 | 2007 | 110 | 0.020 |
Why?
|
HIV Antibodies | 1 | 2014 | 1340 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2017 | 2702 | 0.020 |
Why?
|
Molecular Structure | 1 | 1991 | 1882 | 0.020 |
Why?
|
RNA | 2 | 1998 | 2715 | 0.020 |
Why?
|
HIV | 1 | 2014 | 1591 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2012 | 1676 | 0.020 |
Why?
|
HeLa Cells | 1 | 2012 | 3073 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2017 | 2212 | 0.020 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2004 | 5716 | 0.020 |
Why?
|
Statistics, Nonparametric | 2 | 2004 | 2850 | 0.020 |
Why?
|
Nanoparticles | 1 | 2017 | 1966 | 0.020 |
Why?
|
Cell Lineage | 2 | 2004 | 2575 | 0.020 |
Why?
|
Actins | 1 | 2012 | 2059 | 0.010 |
Why?
|
Aggrecans | 1 | 2004 | 88 | 0.010 |
Why?
|
Ribavirin | 1 | 2006 | 395 | 0.010 |
Why?
|
DNA Methylation | 1 | 2018 | 4426 | 0.010 |
Why?
|
Genomics | 1 | 2020 | 5924 | 0.010 |
Why?
|
Lentivirus | 1 | 2007 | 518 | 0.010 |
Why?
|
Solvents | 1 | 2004 | 298 | 0.010 |
Why?
|
Arthritis, Rheumatoid | 1 | 1999 | 3778 | 0.010 |
Why?
|
Theilovirus | 1 | 2003 | 11 | 0.010 |
Why?
|
Lymphocyte Transfusion | 1 | 2004 | 232 | 0.010 |
Why?
|
Crosses, Genetic | 1 | 2004 | 751 | 0.010 |
Why?
|
Neuraminidase | 1 | 2003 | 192 | 0.010 |
Why?
|
Skin Transplantation | 1 | 2008 | 1097 | 0.010 |
Why?
|
Interferon-alpha | 1 | 2006 | 909 | 0.010 |
Why?
|
Fluorescein | 1 | 2002 | 176 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13646 | 0.010 |
Why?
|
Retroviridae | 1 | 2004 | 846 | 0.010 |
Why?
|
Point Mutation | 1 | 2007 | 1591 | 0.010 |
Why?
|
Blood Platelets | 1 | 2012 | 2464 | 0.010 |
Why?
|
Insulin-Secreting Cells | 1 | 2009 | 898 | 0.010 |
Why?
|
Proteoglycans | 1 | 2004 | 807 | 0.010 |
Why?
|
Staphylococcal Protein A | 1 | 2000 | 39 | 0.010 |
Why?
|
Neurons | 1 | 2020 | 9517 | 0.010 |
Why?
|
Serine | 1 | 2004 | 828 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 2007 | 1854 | 0.010 |
Why?
|
Lung | 1 | 2019 | 10076 | 0.010 |
Why?
|
Extracellular Matrix Proteins | 1 | 2004 | 832 | 0.010 |
Why?
|
Vero Cells | 1 | 2001 | 486 | 0.010 |
Why?
|
Heterozygote | 1 | 2007 | 2794 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 2003 | 1765 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2008 | 2710 | 0.010 |
Why?
|
Virulence Factors, Bordetella | 1 | 1999 | 154 | 0.010 |
Why?
|
Pertussis Toxin | 1 | 1999 | 176 | 0.010 |
Why?
|
Freund's Adjuvant | 1 | 1999 | 144 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2012 | 3582 | 0.010 |
Why?
|
Prognosis | 1 | 2020 | 29963 | 0.010 |
Why?
|
Glycoproteins | 1 | 2007 | 2200 | 0.010 |
Why?
|
Databases, Factual | 1 | 1995 | 8068 | 0.010 |
Why?
|
Immunocompromised Host | 1 | 2004 | 862 | 0.010 |
Why?
|
Yersinia | 1 | 1998 | 9 | 0.010 |
Why?
|
Titrimetry | 1 | 1998 | 36 | 0.010 |
Why?
|
Genes, Immunoglobulin | 1 | 1999 | 283 | 0.010 |
Why?
|
Integrin alpha3beta1 | 1 | 1998 | 53 | 0.010 |
Why?
|
Benzyl Compounds | 1 | 1998 | 19 | 0.010 |
Why?
|
Skin | 1 | 2012 | 4499 | 0.010 |
Why?
|
Aminopeptidases | 1 | 1999 | 114 | 0.010 |
Why?
|
Succinates | 1 | 1998 | 83 | 0.010 |
Why?
|
Biological Transport | 1 | 2003 | 2084 | 0.010 |
Why?
|
Anti-HIV Agents | 1 | 2014 | 4567 | 0.010 |
Why?
|
Leukemia, Erythroblastic, Acute | 1 | 1998 | 176 | 0.010 |
Why?
|
Glutamic Acid | 1 | 2003 | 1182 | 0.010 |
Why?
|
Spleen | 1 | 2004 | 2292 | 0.010 |
Why?
|
Organic Chemicals | 1 | 1998 | 211 | 0.010 |
Why?
|
Oncogene Proteins, Viral | 1 | 1998 | 342 | 0.010 |
Why?
|
Guinea Pigs | 1 | 1998 | 1309 | 0.010 |
Why?
|
Cell Communication | 1 | 2004 | 1660 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2004 | 1965 | 0.010 |
Why?
|
Immunization, Passive | 1 | 1998 | 619 | 0.010 |
Why?
|
Cloning, Molecular | 2 | 1994 | 4167 | 0.010 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 1998 | 564 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1999 | 1531 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2005 | 2647 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1998 | 2551 | 0.010 |
Why?
|
Optic Nerve | 1 | 1998 | 568 | 0.010 |
Why?
|
Cytomegalovirus | 1 | 1998 | 751 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2006 | 3070 | 0.010 |
Why?
|
Algorithms | 1 | 2014 | 14098 | 0.010 |
Why?
|
Polyenes | 1 | 1992 | 68 | 0.010 |
Why?
|
Papillomaviridae | 1 | 1998 | 1139 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 2004 | 3408 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 1998 | 3431 | 0.010 |
Why?
|
Drug Combinations | 1 | 1998 | 2086 | 0.010 |
Why?
|
Oligonucleotide Probes | 1 | 1991 | 416 | 0.010 |
Why?
|
Down-Regulation | 1 | 1998 | 2931 | 0.010 |
Why?
|
Drosophila | 1 | 1998 | 1509 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2011 | 26396 | 0.010 |
Why?
|
Pregnancy | 1 | 2012 | 30238 | 0.010 |
Why?
|
Astrocytes | 1 | 1998 | 1352 | 0.010 |
Why?
|
Serotonin | 1 | 1994 | 1045 | 0.010 |
Why?
|
Blood Glucose | 1 | 2004 | 6421 | 0.010 |
Why?
|
DNA Probes | 1 | 1991 | 541 | 0.010 |
Why?
|
Cyclosporine | 1 | 1992 | 778 | 0.010 |
Why?
|
Jejunum | 1 | 1991 | 474 | 0.010 |
Why?
|
Antigens, CD1 | 1 | 1991 | 434 | 0.000 |
Why?
|
Infant | 1 | 2011 | 36485 | 0.000 |
Why?
|
Genetic Vectors | 1 | 1998 | 3402 | 0.000 |
Why?
|
Tacrolimus | 1 | 1992 | 751 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 36582 | 0.000 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 1998 | 4349 | 0.000 |
Why?
|
Epithelium | 1 | 1991 | 1606 | 0.000 |
Why?
|
Recurrence | 1 | 1998 | 8504 | 0.000 |
Why?
|
Sirolimus | 1 | 1992 | 1539 | 0.000 |
Why?
|
DNA | 1 | 1988 | 7210 | 0.000 |
Why?
|